Journal of Jilin University Medicine Edition ›› 2016, Vol. 42 ›› Issue (01): 85-88.doi: 10.13481/j.1671-587x.20160117

Previous Articles     Next Articles

Differential expression of miRNA in cervical squamous cell carcinoma tissue and significance of its target genes as diagnostic markers

YU Feifei, TIAN Yuxi, LIU Xiaodong, MA Shumei   

  1. Key Laboratory of Radiobiology, Ministry of Health, School of Public Health, Jilin University, Changchun 130021, China
  • Received:2015-06-21 Published:2016-01-26

Abstract:

Objective: To study the differential expression of miRNA in cervical squamous cell carcinoma(CESC)tissue and predict its target genes using bioinformatics methods,and to find the miRNA as tumor markers in the pathological process of CESC.Methods: The CESC samples and their matching normal CESC tissue in TCGA database were download,and the differential expression of genes and miRNAs were screened with statistical method,and the target gene prediction was performed for the differently expressed miRNA with target gene prediction websites.KEGG database was used to analyze the target genes involved in tumor related signaling pathway.Results: Compared with their matching normal CESC tissue,21 miRNA and 1 180 genes were found to be differentially expressed(P<0.05),18 miRNA and 411 genes were up-regulated,and 3 miRNA and 770 genes were down-regulated.7 miRNAs had negative correlationship with the predicted target genes;6 up-regulated miRNA were accompanied by their target genes down-regulation,and down-regulated 1 miRNA were accompanied by their target genes up-regulation;their target genes were involved in Wnt,MAPK,P53 and cAMP tumor related signaling pathways.Conclusion: The differentially expressed miRNAs including hsa-miR-27a,hsa-miR-148b,hsa-miR-185,hsa-miR-200a,hsa-miR-200b,hsa-miR-221 and hsa-mir-133b and their target genes play important roles in the development of CESC,and they are possible to become the tumor markers in the diagnosis of CESC.

Key words: cervical squamous cell carcinoma, microRNA, tumor marker

CLC Number: 

  • R737.33